Alternatives to antibiotics—a pipeline portfolio review
Antibiotics have saved countless lives and enabled the development of modern medicine over the past 70 years. However, it is clear that the success of antibiotics might only have been temporary and we now expect a long-term and perhaps never-ending challenge to fi nd new therapies to combat antibiotic-resistant bacteria. A broader approach to address bacterial infection is needed. In this Review, we discuss alternatives to antibiotics, which we defi ned as non-compound approaches (products other than classic antibacterial agents) that target bacteria or any approaches that target the host.